Skip to main content

Want a detailed portfolio tracker?

Disc Medicine (IRON) P/E (2020 - 2026)

Disc Medicine (IRON) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Disc Medicine (IRON) P/E is -11.39. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Disc Medicine (IRON)

YearP/EChange
2026-11.39-14.54%
2025-13.33-18.85%
2024-16.43-12.03%
2023-18.68+279.31%
2022-4.92+41.61%
2021-3.48-97.09%
2020-119.65N/A

Comparison Disc Medicine (IRON) P/E with competitors

Disc Medicine (IRON) P/E is -11.39.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.66%
FGENFibroGen Inc0.24-102.11%
CHRSCoherus Biosciences Inc0.85-107.45%
FBIOFortress Biotech Inc0.95-108.33%
ORMPOramed Pharmaceuticals Inc1.50-113.19%
AGENAgenus Inc3.01-126.41%
INVAInnoviva Inc3.15-127.68%
VXRTVaxart Inc3.55-131.15%
CRMDCorMedix Inc3.63-131.84%
CVACCureVac N.V.4.45-139.01%
GLPGGalapagos NV4.86-142.64%
SRPTSarepta Therapeutics Inc4.88-142.84%
ABEOAbeona Therapeutics Inc5.39-147.28%
ABUSArbutus Biopharma Corp5.60-149.11%
ZVRAZevra Therapeutics Inc5.89-151.66%
SPROSpero Therapeutics Inc6.23-154.66%
CGENCompugen Ltd6.31-155.41%
RIGLRigel Pharmaceuticals6.87-160.31%
SLXNSilexion Therapeutics Corp7.30-164.03%
OMEROmeros Corporation9.26-181.25%
AUPHAurinia Pharmaceuticals Inc9.58-184.11%
PLXProtalix BioTherapeutics Inc10.89-195.58%
ACADAcadia Pharmaceuticals Inc11.73-202.93%
TBPHTheravance Biopharma Inc12.26-207.61%
ADMAAdma Biologics Inc12.42-208.98%
HRMYHarmony Biosciences Holdings Inc13.82-221.28%
SABSSAB Biotherapeutics Inc14.14-224.05%
NAGENiagen Bioscience Inc14.82-230.04%
INCYIncyte Corp15.82-238.85%
REGNRegeneron Pharmaceuticals Inc15.86-239.15%
PBYIPuma Biotechnology Inc17.32-251.96%
CPRXCatalyst Pharmaceuticals Inc17.44-253.04%
EXELExelixis Inc17.54-253.91%
TGTXTG Therapeutics Inc18.97-266.44%
MDXGMimedx Group Inc20.55-280.36%
XOMAXOMA Royalty Corp22.87-300.75%
ARGXArgen X SE24.30-313.24%
CTMXCytomX Therapeutics Inc24.82-317.83%
XOMAOXOMA Royalty Corp25.34-322.42%
HALOHalozyme Therapeutics Inc25.62-324.87%
XOMAPXOMA Royalty Corp25.67-325.28%
VRTXVertex Pharmaceuticals Inc27.99-345.68%
RPRXRoyalty Pharma plc - Class A28.69-351.76%
SLNOSoleno Therapeutics Inc29.02-354.64%
ASNDAscendis Pharma A/S30.09-364.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-432.71%
APLSApellis Pharmaceuticals Inc39.02-442.45%
BMRNBiomarin Pharmaceutical Inc42.21-470.45%
KRYSKrystal Biotech Inc45.34-497.93%
ONCBeiGene Ltd69.54-710.28%
PHARPharming Group N.V.75.03-758.42%
TECHBio-Techne Corp101.96-994.78%
VCELVericel Corp109.92-1064.66%
ALNYAlnylam Pharmaceuticals Inc117.96-1135.25%
GMABGenmab140.29-1331.18%
TLXTelix Pharmaceuticals Ltd162.15-1523.04%
CORTCorcept Therapeutics Inc212.86-1968.02%